Masanori Nakagawa Selected Research

Multiple Sclerosis

1/2018	Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
10/2016	Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Nakagawa Research Topics

Disease

8	Alexander Disease (Alexander's Disease) 10/2019 - 03/2002
8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2009
8	Cognitive Dysfunction 01/2018 - 03/2007
8	Parkinson Disease (Parkinson's Disease) 01/2017 - 10/2006
7	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 11/2005
6	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 06/2022 - 01/2003
6	Dementia (Dementias) 01/2018 - 11/2005
5	Disease Progression 03/2024 - 12/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 07/2009
4	Muscular Diseases (Myopathy) 01/2017 - 12/2010
4	Myasthenia Gravis 11/2016 - 09/2005
3	Spinal Cord Diseases 03/2024 - 08/2007
3	Infections 11/2023 - 01/2006
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2023 - 01/2007
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2004
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2022 - 06/2008
3	Hypertension (High Blood Pressure) 10/2021 - 01/2005
3	CADASIL 09/2020 - 01/2008
3	Stroke (Strokes) 09/2020 - 03/2005
3	Infarction (Infarctions) 01/2018 - 02/2008
3	Seizures (Absence Seizure) 01/2017 - 04/2009
3	Parkinsonian Disorders (Parkinsonism) 01/2017 - 01/2010
3	Meningitis 01/2015 - 02/2009
2	T-Cell Leukemia (Leukemia, T Cell) 03/2024 - 01/2016
2	Amyloidosis 06/2022 - 01/2009
2	Hypoxia (Hypoxemia) 03/2022 - 01/2003
2	Neuromyelitis Optica (Devic's Disease) 06/2018 - 04/2011
2	Multiple Sclerosis 01/2018 - 10/2016
2	Neoplasms (Cancer) 09/2017 - 08/2009
2	Multiple System Atrophy 01/2016 - 06/2014
2	Progressive Bulbar Palsy (Fazio Londe Syndrome) 07/2015 - 12/2013
2	Inflammation (Inflammations) 01/2015 - 11/2009
2	Dermatomyositis (Dermatopolymyositis) 05/2014 - 01/2009
2	Muscle Weakness 12/2013 - 01/2009
2	Mood Disorders (Mood Disorder) 04/2012 - 10/2009
2	Schizophrenia (Dementia Praecox) 03/2012 - 10/2009
2	Neuroleptic Malignant Syndrome 01/2012 - 01/2011
2	Polymyositis 09/2011 - 01/2009
2	Atherosclerosis 10/2010 - 11/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2009 - 01/2003
2	Glioma (Gliomas) 10/2002 - 02/2002
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2023
1	Acquired CJD 01/2023
1	Gliosis 01/2023
1	Spinal Diseases (Disease, Spinal) 01/2021
1	Leukoencephalopathies 01/2020
1	Rare Diseases (Rare Disease) 10/2019
1	Inclusion Body Myositis 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2018
1	Trigeminal Neuralgia (Tic Douloureux) 11/2017
1	Hemifacial Spasm 11/2017

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2013
8	Glial Fibrillary Acidic ProteinIBA 10/2019 - 03/2002
5	Amyloid (Amyloid Fibrils)IBA 01/2017 - 11/2005
5	SynucleinsIBA 01/2015 - 01/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 01/2010
4	Mitochondrial DNA (mtDNA)IBA 09/2011 - 04/2002
3	SteroidsIBA 03/2022 - 08/2013
3	Myelin P0 Protein (Myelin Protein Zero)IBA 01/2021 - 01/2003
3	Prednisolone (Predate)FDA LinkGeneric 06/2018 - 01/2009
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 08/2013
3	alpha-SynucleinIBA 08/2010 - 10/2006
2	Aquaporins (Water Channels)IBA 01/2023 - 04/2011
2	Prealbumin (Transthyretin)IBA 06/2022 - 01/2009
2	lomerizineIBA 09/2020 - 03/2009
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 02/2002
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018 - 09/2011
2	fibrin fragment D (D-dimer)IBA 01/2018 - 01/2005
2	GadoliniumIBA 09/2017 - 01/2011
2	AntibodiesIBA 01/2017 - 01/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2013 - 04/2009
2	InterferonsIBA 01/2012 - 01/2004
2	AntigensIBA 03/2011 - 05/2002
2	DNA-Binding Proteins (DNA Binding Protein)IBA 03/2011 - 01/2009
2	Amyloid beta-PeptidesIBA 08/2010 - 12/2009
2	Indicators and Reagents (Reagents)IBA 02/2010 - 02/2008
2	CytokinesIBA 11/2009 - 01/2006
2	Interferon-alpha (Interferon Alfa)IBA 08/2007 - 01/2004
1	mogamulizumabIBA 03/2024
1	NeopterinIBA 03/2024
1	Messenger RNA (mRNA)IBA 11/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Prion ProteinsIBA 01/2023
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 10/2021
1	Dihydrotachysterol (AT 10)IBA 09/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	Protein AggregatesIBA 01/2019
1	mecobalamin (methylcobalamin)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2018

Therapy/Procedure

10	Therapeutics 12/2022 - 01/2004
2	Immunotherapy 01/2017 - 11/2005
2	Activities of Daily Living (ADL) 12/2013 - 03/2007
2	Radiotherapy 04/2011 - 08/2009
1	Secondary Prevention 09/2020